GSK
GlaxoSmithKline PLC ADRNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$105.95B
P/E Ratio
13.95
EPS
$3.79
Beta
0.29
52W High
$60.65
52W Low
$34.17
50-Day MA
$53.10
200-Day MA
$49.77
Dividend Yield
3.41%
Profit Margin
17.80%
Forward P/E
11.35
PEG Ratio
10.23
About GlaxoSmithKline PLC ADR
GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, over-the-counter drugs and health-related consumer products in the UK, US and internationally. The company is headquartered in Brentford, the United Kingdom.
Fundamentals
| Revenue (TTM) | $32.78B |
| Gross Profit (TTM) | $23.89B |
| EBITDA | $11.43B |
| Operating Margin | 36.30% |
| Return on Equity | 40.90% |
| Return on Assets | 10.00% |
| Revenue/Share (TTM) | $16.25 |
| Book Value | $11.95 |
| Price-to-Book | 4.45 |
| Price-to-Sales (TTM) | 3.23 |
| EV/Revenue | 2.876 |
| EV/EBITDA | 9.35 |
| Quarterly Earnings Growth (YoY) | 8.40% |
| Quarterly Revenue Growth (YoY) | 1.50% |
| Shares Outstanding | $2.00B |
| Float | $1.95B |
| % Insiders | 0.06% |
| % Institutions | 18.84% |
Historical Volatility
HV 10-Day
29.47%
HV 20-Day
24.18%
HV 30-Day
22.09%
HV 60-Day
25.76%
HV Rank
19.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($56.63 target)
1
Strong Buy1
Buy5
Hold1
SellMore HEALTHCARE Stocks
Data last updated: 6/13/2026